Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | etoposide | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.082 | 0.06 |
mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.06 |
mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.06 |
mRNA | prochlorperazine | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |